◀ Back to PTGS2
CSF2 — PTGS2
Text-mined interactions from Literome
Stanford et al., Br J Pharmacol 2000
:
Here we demonstrate, for the first time, that co-induced
COX-2 activity simultaneously
suppresses GM-CSF release and potentiates G-CSF release by human vascular cells ... Moreover, the differential
regulation of
GM-CSF and G-CSF release by
COX-2 was mimicked by the prostacyclin ( PGI ( 2 ) ) mimetic, cicaprost
Stanford et al., Arterioscler Thromb Vasc Biol 2000
(Arteriosclerosis) :
Cyclooxygenase-2 regulates granulocyte-macrophage
colony stimulating factor , but not interleukin-8, production by human vascular cells : role of cAMP ... Under the same conditions, we found that
COX-2 activity
suppressed GM-CSF , but not IL-8, release by both types of human vascular cells
Calatayud et al., Br J Pharmacol 2001
(Colonic Neoplasms) :
4. No changes in any
CSF release or HT-29 cell apoptosis were detected in the
presence of the
COX-2 selective inhibitor DFP ( 10 ( -7 ) -10 ( -4 ) M )
Nakata et al., Cancer Sci 2003
(Disease Progression...) :
It is known that increased COX-2 activity promotes tumor growth and
induces G-CSF and
GM-CSF expression in non-malignant cells, and that selective
COX-2 inhibitors inhibit the growth of some types of malignant cells ... Therefore, we hypothesized that inhibition of
COX-2 activity might
suppress constitutive production of G-CSF or
GM-CSF in addition to reducing the growth of malignant cells ... We confirmed that the selective
COX-2 inhibitor, NS-398
suppressed the constitutive production of G-CSF and
GM-CSF , and the cell growth in both OKa-C-1 and MI-4 cell lines
Jiang et al., Mol Cell Biochem 2003
:
In this study, the
effect of phorbol 12-myristate 13-acetate ( PMA ), tumor necrosis factor alpha (TNFalpha), lipopolysaccharide (LPS) and
macrophage-colony stimulating factor ( M-CSF ) on AA release and prostaglandin E2 ( PGE2 ) production and the expression of cPLA2 and
COX-1 and -2 were investigated in U937 human pre-monocytic cells and fully differentiated macrophages
Wang et al., Fertil Steril 2006
:
After treatment of 12 hours, low-dose
GM-CSF ( 0.001-0.1 ng/mL )
increased COX-2 mRNA levels in stromal cell, whereas high dose GM-CSF ( 1-100 ng/mL ) decreased COX-1 and COX-2 mRNA levels ... There appeared to be a biphasic pattern of
COX-2 enzyme
response to
GM-CSF with low concentrations increasing activity and high concentrations inhibiting activity
Shoji et al., Acta Biochim Biophys Sin (Shanghai) 2007
:
By itself, nicotine did not affect expression of COX-1, COX-2, any of the PGE ( 2 ) receptors, or
M-CSF , but when both nicotine and LPS were present, expression of
COX-2 , Ep3, Ep4, and M-CSF
increased significantly
Sanuki et al., Connect Tissue Res 2010
:
Celecoxib, a specific inhibitor of
COX-2 ,
blocked the stimulatory effect of CF on TRAP staining and the production of PGE ( 2 ),
M-CSF , RANKL, and OPG